Biography
Steven Lemery
Medical Oncologist and Acting Director of the Division of Oncology 3 within the Office of Oncologic Diseases
FDA
Dr. Lemery is a medical oncologist and the Acting Director of the Division of Oncology 3 within the Office of Oncologic Diseases within CDER/FDA. In addition to duties regarding general drug development for patients with cancer, Dr. Lemery has also focused on tissue-agnostic development and biosimilar development. Prior to assuming the role of Acting Director, he served as an Associate Division Director of the former Division of Oncology Products 2 and Team Leader (Lead Medical Officer) of the gastrointestinal malignancies team. Dr. Lemery completed his clinical training in hematology and medical oncology at the National Institutes of Health in Bethesda, Maryland. Dr. Lemery also graduated with a Master of Health Sciences in Clinical Research degree awarded by the Duke University School of Medicine (joint NIH/Duke program).